2025年，相城高新区锚定"1368"发展战略，通过"管委会+公司"招商体制机制改革，构建 起"3+3+5+11"特色招商体系，科招、产招、服务业、创投、文产五大国资公司揭牌运营，11支招商先 锋队主动出击、精准发力，成功招引中讯创科、中飞遥感、苏州万洋科技城等112个重点项目签约落 户，总投资超118亿元，圆满实现招商"双百"目标，奋力开创相城高新区高质量发展新局面。新年伊 始，更是捷报频传。1月21日，爱舍伦成功登陆北交所，成为相城本土培育的首家北交所上市企业，打 响2026年江苏A股上市"第一枪"；总投资超10亿元的汉勃科技项目抢滩落户，为一季度实现"开门红"按 下快进键。 昨天（1月26日），2026年相城高新区（元和街道）招商引资工作推进会暨"三服务"工作动员会召 开，总结回顾2025年招商工作成效，部署落实2026年招商工作举措，全面吹响2026年招商引资攻坚号 角。 会议明确了2026年招商工作的发力方向，在五大招商公司良性运转的基础上，拟设立上海招商公 司，紧抓沪苏（州）同城化机遇，主动承接上海（长三角）国际科创中心功能溢出，融入"大虹桥"建 设，精准招引高端商务、会展经济、交通物流、研发创新 ...

每经讯，爱舍伦1月26日发布公告称，为强化海外市场战略布局，公司拟使用自有资金和自筹资金由香 港子公司EXCELLENT MEDICAL TECHNOLOGY CO., LIMITED向摩洛哥孙公司增加1,500万欧元投资 额（即总投资额不超过2,000万欧元），加快摩洛哥孙公司创新医疗的生产基地建设。本次增资拟主要 用于和当地公司CRBC TANGER LIMITED（中国路桥下属公司，施工总承包人）、Lecons Group SARL （施工方）签署建筑工程施工合同，由其承建爱舍伦摩洛哥子公司位于丹吉尔科技城工厂厂房建设的第 一期工程项目；合同总金额为1.5175亿摩洛哥迪拉姆（约1410万欧元）。公司董事会授权管理层办理与 本次对外投资相关的具体事项，包括但不限于进行相关磋商、签订相关法律文件、向有关机构办理审批 备案等手续。 （记者 曾健辉） 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 ...

本报告导读： 1 月第 3 周 A 股市场指数表现分化，中小盘股票表现相对较优，沪深北三市交易活 跃度均有所下降，北证日均成交金额环比下降 34.33%至 264.07 亿元，北证 50 指数 单周上涨 2.60%。当周北交所 1 只新股招股，2 只新股上市，新股上市首日均价涨 幅仍维持 150%以上高位。 投资要点： 新股研究 /[Table_Date] 2026.01.26 北证日均成交金额有所回落，北证 50 指 数单周上涨 2.60% ——北交所周报（2026 年 1 月第 3 周） | [Table_Authors] | | | --- | --- | | | 王政之(分析师) | | | 021-38674944 | | | wangzhengzhi@gtht.com | | 登记编号 | S0880517060002 | | | 施怡昀(分析师) | | | 021-38032690 | | | shiyiyun@gtht.com | | 登记编号 | S0880522060002 | | | 王思琪(分析师) | | | 021-38038671 | | | wangsiqi3@gtht.co ...

证券代码：920050 证券简称：爱舍伦 公告编号：2026-009 江苏爱舍伦医疗科技集团股份有限公司 关于增加摩洛哥孙公司投资额暨签署重大合同的公告 为强化海外市场战略布局，公司拟使用自有资金和自筹资金由香港子公司 EXCELLENT MEDICAL TECHNOLOGY CO., LIMITED 向摩洛哥孙公司增加 1,500 万欧元投资额（即总投资额不超过 2,000 万欧元），加快摩洛哥孙公司创新 医疗的生产基地建设。本次增资拟主要用于和当地公司 CRBC TANGER LIMITED（中国路桥下属公司，施工总承包人）、Lecons Group SARL（施工方） 签署建筑工程施工合同，由其承建爱舍伦摩洛哥子公司位于丹吉尔科技城工厂厂 房建设的第一期工程项目；合同总金额为 1.5175 亿摩洛哥迪拉姆（约 1410 万欧 元）。公司董事会授权管理层办理与本次对外投资相关的具体事项，包括但不限 于进行相关磋商、签订相关法律文件、向有关机构办理审批备案等手续。 （二）是否构成重大资产重组 本次交易不构成重大资产重组。 依据《上市公司重大资产重组管理办法》的相关规定，公司本次对外投资不 构成重大资产重组。 ...

第二届董事会第十七次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 证券代码：920050 证券简称：爱舍伦 公告编号：2026-010 江苏爱舍伦医疗科技集团股份有限公司 （一）会议召开情况 1.会议召开时间：2026 年 1 月 23 日 2.会议召开地点：苏州市相城区相城大道 1539 号公司会议室 3.会议召开方式：现场会议 4.发出董事会会议通知的时间和方式：2026 年 1 月 16 日以通讯方式发出 5.会议主持人：董事长张勇先生 6.会议列席人员：公司高级管理人员 （一）审议通过《关于增加摩洛哥孙公司投资额暨签署重大合同的议案》 1.议案内容： 为强化海外市场战略布局，公司拟使用自有资金和自筹资金由香港子公司 EXCELLENT MEDICAL TECHNOLOGY CO., LIMITED 向摩洛哥孙公司创新医疗增加 1,500 万欧元投资额（即总投资额不超过 2,000 万欧元），加快摩洛哥孙公司的 生产基地建设。本次增资拟主要用于和当地公司 C ...

爱舍伦公告，公司拟使用自有资金和自筹资金由香港子公司向摩洛哥孙公司创新医疗增加1500万欧元投 资额，即总投资额不超过2000万欧元，加快生产基地建设。本次增资主要用于与当地公司签署建筑工程 施工合同，由其承建爱舍伦摩洛哥子公司位于丹吉尔科技城工厂厂房建设的第一期工程项目，合同总金 额为1.52亿摩洛哥迪拉姆（约1410万欧元）。 ...

IPO Pipeline Overview - As of January 25, there are 323 companies in the IPO pipeline, with 21 on the Shanghai Main Board, 42 on the Sci-Tech Innovation Board, 19 on the Shenzhen Main Board, 39 on the Growth Enterprise Market, and 202 on the Beijing Stock Exchange [1][2]. Newly Listed Companies - Two companies were newly listed between January 19 and January 25: Jiangsu Aisheren Medical Technology Group Co., Ltd. and Hebei Guoliang New Materials Co., Ltd. Both are listed on the Beijing Stock Exchange [3][4]. - Jiangsu Aisheren closed at 44.04 yuan per share, with a rise of 175.59% and a trading volume of 689 million yuan, achieving a turnover rate of 78.23% on its first day [4]. - Hebei Guoliang closed at 28.06 yuan per share, with a rise of 160.78% and a trading volume of 483 million yuan, achieving a turnover rate of 81.73% on its first day [4]. New Counseling Record Companies - A total of 20 companies were newly recorded for counseling between January 19 and January 25, including Guangdong Lanrui Technology Group Co., Ltd. and Huaxin Technology (Beijing) Co., Ltd. [5][6]. Companies Approved for Review - Six companies successfully passed the review process from January 19 to January 25, including Wuxi Lichi Intelligent Equipment Co., Ltd. and Wuhu Aiteke Automotive Electronics Co., Ltd. [12][13]. - Wuxi Lichi specializes in automated material handling systems for various industries, including lithium battery manufacturing and fine chemicals [13]. Companies Approved for Registration - Five companies received registration approval between January 19 and January 25, including Zhejiang Xinhengtai New Materials Co., Ltd. and Shandong Yuelong Rubber and Plastic Technology Co., Ltd. [16][17]. - Zhejiang Xinhengtai focuses on functional polymer foaming materials, while Shandong Yuelong specializes in flexible pipeline products for fluid transportation [17]. Terminated Review Cases - Nanjing Qinheng Microelectronics Co., Ltd. withdrew its IPO application during the period [20][21].

Group 1 - The core point of the news is the issuance of new stocks in the market, with a total of 10 companies raising a cumulative amount of 9.99 billion yuan this year, with an average fundraising of 914 million yuan per company [1][2] - North Chip Life issued 57 million shares at a price of 17.52 yuan, raising 999 million yuan [1] - The highest fundraising company this year is Zhenstone Co., which raised 2.919 billion yuan, primarily for the construction of glass fiber product production bases and composite material production bases [1] Group 2 - The average initial public offering (IPO) price for new stocks this year is 27.60 yuan, with the highest being Hengyun Chang at 92.18 yuan [2] - The geographical distribution of new stock issuances is mainly concentrated in Guangdong, Zhejiang, and Jiangsu, with the highest fundraising amounts from Zhejiang (3.163 billion yuan), Guangdong (2.559 billion yuan), and Chongqing (1.240 billion yuan) [2] - The table lists various companies that have issued new stocks this year, including their stock codes, issuance dates, total shares issued, issue prices, and fundraising amounts [2]

美德乐最新披露的发行结果显示，该股吸引了59.25万户参与打新，有效申购数量252.83亿股，最终 6.1万户获配，网上中签率0.057%，冻结资金共计1.06万亿。 2026.01. 26 本文字数：852，阅读时长大约2分钟 作者 | 第一财 经 周楠 北交所市场的打新热度一再攀高，个股冻结资金规模首次突破1万亿。 按照上市日期，3只个股科马材料、爱舍伦、国亮新材，分别于1月16日、21日和22日登陆北交所， 打新冻资规模分别达到8557.65亿元、8789.21亿元和8280.77亿元，打新中签率在0.02%和0.03% 左右。 对于北交所新股市场，近期，北京南山投资创始人周运南告诉记者，北交所新股冻资规模持续保持高 位，释放出赚钱效应，市场高度期待北交所的新股上市提速、高质量扩容。 据招股书，美德乐主营业务为智能制造装备的研发、设计、制造和销售，2024年7月在新三板挂牌。 记者获悉，该股通过直联审核机制申报北交所，去年5月底上市申请获受理，当年11月底过会，一个 月后注册生效。 披露显示，美德乐拟发行股份数量1600万股，募集资金6.45亿元，发行价格41.88元，发行市盈率 14.99倍，于1月2 ...

Group 1 - The Beijing Stock Exchange has welcomed three new listings, bringing the total number of listed companies to 290 and the total market capitalization to 967.05 billion yuan, approaching the 1 trillion yuan mark [1] - The IPO review process on the Beijing Stock Exchange is maintaining a high frequency, with expectations for continued rapid issuance of IPOs due to deepening market reforms [1] Group 2 - The semiconductor industry is experiencing strong performance driven by demand from artificial intelligence, with many companies reporting increased operating rates in chip manufacturing [2] - A total of 506 A-share companies have forecasted net profit growth for 2025, with 16 companies expecting growth exceeding 500%, driven by factors such as market expansion and cost reduction [12] Group 3 - The mandatory disclosure of ESG reports is transforming the quality and comparability of data, moving from qualitative case studies to quantitative data points, enhancing transparency in environmental information [3] - The shift towards a more systematic approach in regulatory oversight of listed companies is evident, with over 90 companies facing administrative penalties in 2025, indicating a stricter enforcement environment [6][7] Group 4 - The short-term funding environment is expected to remain reasonably ample, with the People's Bank of China focusing on guiding overnight rates to operate near policy rate levels [4] - The A-share market is witnessing a structural opportunity, with a focus on technology growth and resource sectors as brokers conduct extensive research on companies [8] Group 5 - The new fund establishment has reached 76 this year, raising a total of 71.939 billion yuan, with a significant number of funds achieving over 20% returns, indicating strong investor interest [10] - The proactive equity funds are heavily invested in the electronics, pharmaceuticals, and power equipment sectors, reflecting a strategic focus on high-growth industries [14]